Log In
person
Catalyst Pharmaceutical Inc
CPRX
summarize
2 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Rare Diseases |
Branded Pharmaceuticals (outsourced)
These companies research, develop, and outsource the manufacturing of patented drugs.
|
396.5M | 99.57% |
| Rare Diseases |
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
1.7M | 0.43% |
| keyboard_arrow_down |
Rare Diseases
Branded Pharmaceuticals (outsourced)
|
396.5M | 99.57% |
| keyboard_arrow_right |
These companies research, develop, and outsource the manufacturing of patented drugs.
|
||
| keyboard_arrow_down |
Rare Diseases
Pharmaceutical Patent Licensing
|
1.7M | 0.43% |
| keyboard_arrow_right |
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
||